BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7679964)

  • 1. CD20 (pan-B cell) antigen is expressed at a low level on a subpopulation of human T lymphocytes.
    Hultin LE; Hausner MA; Hultin PM; Giorgi JV
    Cytometry; 1993; 14(2):196-204. PubMed ID: 7679964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low level CD20 expression on T cell malignancies.
    Warzynski MJ; Graham DM; Axtell RA; Zakem MH; Rotman RK
    Cytometry; 1994 Jun; 18(2):88-92. PubMed ID: 7523045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
    Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
    Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The HML-1 antigen of intestinal lymphocytes is an activation antigen.
    Schieferdecker HL; Ullrich R; Weiss-Breckwoldt AN; Schwarting R; Stein H; Riecken EO; Zeitz M
    J Immunol; 1990 Apr; 144(7):2541-9. PubMed ID: 1690770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating CD20dim T-lymphocytes increase with age: evidence for a memory cytotoxic phenotype.
    Storie I; Wilson GA; Granger V; Barnett D; Reilly JT
    Clin Lab Haematol; 1995 Dec; 17(4):323-8. PubMed ID: 8697727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of the Fc receptor for IgG (Fc gamma RII/CDw32) by human circulating T and B lymphocytes.
    Mantzioris BX; Berger MF; Sewell W; Zola H
    J Immunol; 1993 Jun; 150(11):5175-84. PubMed ID: 8496609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features.
    D'Arena G; Musto P; Cascavilla N; Di Giorgio G; Fusilli S; Zendoli F; Carotenuto M
    Haematologica; 1998 Mar; 83(3):197-203. PubMed ID: 9573672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
    Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
    J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis.
    Ginaldi L; De Martinis M; D'Ostilio A; Marini L; Loreto F; Modesti M; Quaglino D
    Am J Hematol; 2001 Jun; 67(2):63-72. PubMed ID: 11343377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subset analysis by Boolean algebra: a phenotypic approach using a cocktail of 5 antibodies and 3 color immunofluorescence.
    Hunter SD; Peters LE; Wotherspoon JS; Crowe SM
    Cytometry; 1994 Mar; 15(3):258-66. PubMed ID: 7514523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M; Babusíková O
    Neoplasma; 1998; 45(4):237-42. PubMed ID: 9890667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R; Yssel H; de Vries JE
    J Immunol; 1993 Jun; 150(11):4754-65. PubMed ID: 7684412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of human leukocyte-specific monoclonal antibodies for clinically immunophenotyping lymphocytes of rhesus monkeys.
    Reimann KA; Waite BC; Lee-Parritz DE; Lin W; Uchanska-Ziegler B; O'Connell MJ; Letvin NL
    Cytometry; 1994 Sep; 17(1):102-8. PubMed ID: 8001455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD20-positive T-cell chronic lymphocytic leukaemia.
    Takami A; Saito M; Nakao S; Asakura H; Nozue T; Onoe Y; Yachie A; Shiobara S; Matsuda T
    Br J Haematol; 1998 Sep; 102(5):1327-9. PubMed ID: 9753064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of functionally active CD20+ T cells by rituximab treatment.
    Wilk E; Witte T; Marquardt N; Horvath T; Kalippke K; Scholz K; Wilke N; Schmidt RE; Jacobs R
    Arthritis Rheum; 2009 Dec; 60(12):3563-71. PubMed ID: 19950291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of a novel CD2+ human thymic B cell subset.
    Punnonen J; de Vries JE
    J Immunol; 1993 Jul; 151(1):100-10. PubMed ID: 7686927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies.
    Koshiba M; Rosin DL; Hayashi N; Linden J; Sitkovsky MV
    Mol Pharmacol; 1999 Mar; 55(3):614-24. PubMed ID: 10051547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peripheral blood cell preparation influences the level of expression of leukocyte cell surface markers as assessed with quantitative multicolor flow cytometry.
    Islam D; Lindberg AA; Christensson B
    Cytometry; 1995 Jun; 22(2):128-34. PubMed ID: 7587743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct signal transduction in mouse CD4+ and CD8+ splenic T cells after CD28 receptor ligation.
    Abe R; Vandenberghe P; Craighead N; Smoot DS; Lee KP; June CH
    J Immunol; 1995 Feb; 154(3):985-97. PubMed ID: 7822814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.